title: Safety profile of bone marrow mononuclear stem cells in the rehabilitation of patients with posttraumatic facial nerve paralysis-a novel modality (phase one trial).
abstract: Objectives The objectives of this study were to study the safety profile and role of mononuclear stem cells in the rehabilitation of posttraumatic facial nerve paralysis not improving with conventional treatment. Study Design This is a prospective nonrandomized controlled trial. Study Setting This study is conducted at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh between July, 2007 and December, 2008. Patients We included eight patients of either sex aged between 18 and 60 years of posttraumatic facial nerve paralysis not improving with conventional treatment presented to PGIMER, Chandigarh between July 2007 and December 2008. Methods All patients underwent preoperative electroneuronography (ENoG), clinical photography, and high-resolution computed tomography (HRCT) temporal bone. All patients then underwent facial nerve decompression and stem cell implantation. Stem cells processing was done in well-equipped bone marrow laboratory. Postoperatively, all patients underwent repeat ENoG and clinical photography at 3 and 6 months to assess for objective and clinical improvement. Clinical improvement was graded according to modified House-Brackmann grading system. Intervention Done All patients of posttraumatic facial nerve paralysis who were not improving with conventional surgical treatment were subjected to facial nerve decompression and stem cell implantation. Main Outcome Measures All patients who were subjected to stem cell implantation were followed up for 6 months to assess for any adverse effects of stem cell therapy on human beings; no adverse effects were seen in any of our patients after more than 6 months of follow-up. Results Majority of the patients were male, with motor vehicle accidents as the most common cause of injury in our series. Majority had longitudinal fractures on HRCT temporal bone. The significant improvement in ENoG amplitude was seen between preoperative and postoperative amplitudes on involved side which was statistically significant (0.041). Clinical improvement seen was statistically significant both for eye closure (p < 0.010) and for deviation of angle of mouth (p < 0.008) at 6-month follow-up in 85% of our patients, far better than the results of previous conventional surgeries. Conclusion Stem cell therapy can be used safely in human beings without any adverse effects on humans, and it appears to be a promising modality for rehabilitation of patients with posttraumatic facial nerve paralysis not improving with conventional surgical treatment but few more clinical series are required for validation.
authors.affiliation: Department of Neuro-Otology, SGPGIMS, Lucknow, Uttar Pradesh, India.
authors.forename: Sushil Kumar
authors.initials: SK
authors.lastname: Aggarwal
authors.forename: Ashok Kumar
authors.initials: AK
authors.lastname: Gupta
authors.forename: Manish
authors.initials: M
authors.lastname: Modi
authors.forename: Rijuneeta
authors.initials: R
authors.lastname: Gupta
authors.forename: Neelam
authors.initials: N
authors.lastname: Marwaha
keywords: rehabilitation; stem cell therapy; traumatic facial nerve paralysis
references.citation: Acta Otolaryngol. 2001 Jul;121(5):652-5
references.pmid: 11583403
references.citation: Am J Otol. 1985 May;6(3):207-15
references.pmid: 4003527
references.citation: Am J Emerg Med. 1995 Mar;13(2):211-4
references.pmid: 7893311
references.citation: Am J Otol. 1984 Oct;5(6):494-8
references.pmid: 6393772
references.citation: Otolaryngol Head Neck Surg. 1982 Sep-Oct;90(5):612-5
references.pmid: 6819523
references.citation: Laryngoscope. 1979 Sep;89(9 Pt 1):1432-5
references.pmid: 481048
references.citation: Am J Otol. 1992 Mar;13(2):167-72
references.pmid: 1599010
references.citation: Oncogene. 2000 Jun 15;19(26):2957-66
references.pmid: 10871847
references.citation: Nat Med. 2004 Mar;10(3):224-5
references.pmid: 14991036
references.citation: Arch Otolaryngol. 1983 May;109(5):285-8
references.pmid: 6847478
references.citation: Ann Otol Rhinol Laryngol. 1963 Sep;72:735-55
references.pmid: 14062422
references.citation: Am J Otol. 1997 Mar;18(2):188-97
references.pmid: 9093676
references.citation: Laryngoscope. 1990 Oct;100(10 Pt 1):1062-7
references.pmid: 2215037
references.citation: Arch Otolaryngol. 1981 Jan;107(1):1-11
references.pmid: 7469872
references.citation: Laryngoscope. 2006 Aug;116(8):1363-7
references.pmid: 16885736
references.citation: Otolaryngol Head Neck Surg. 1985 Apr;93(2):146-7
references.pmid: 3921901
references.citation: Otolaryngol Head Neck Surg. 1994 Nov;111(5):606-10
references.pmid: 7970799
references.citation: Arch Otolaryngol. 1985 Dec;111(12):781-5
references.pmid: 4062648
references.citation: Otolaryngol Clin North Am. 1991 Jun;24(3):613-45
references.pmid: 1762779
references.citation: J Trauma. 1994 Feb;36(2):198-201
references.pmid: 8114136
references.citation: Neuroreport. 2004 Jan 19;15(1):1-4
references.pmid: 15106820